Clinical trial
Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection
NCT02711176 is registered in ClinicalTrials.gov with Zahra Vahdat Shariatpanahi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection
- Lead sponsor
- Zahra Vahdat Shariatpanahi
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2016
- Completion date
- March 27, 2017
- Enrollment
- 212 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
helicobacter infection